var CR_LINK_TEXT = "From the January 2012 Issue of EyeWorld –";
var CR_MONTH = "Retina co-morbidity for the anterior segment surgeon  ";
var CR_INFO = [
    {
        title: "Consider the macula in pre-op cataract patients",
        author: "Jena Passut EyeWorld Staff Writer",
        content: "Surgical complications arise, even in cataract surgery, which reportedly has one of the highest success rates. Yet despite all the various pre-op tests that are performed to ensure a successful operation—from measuring the eye and cornea to deciding on the best IOL fit—there are always potential problems that may be overlooked during the procedure, especially from the back of the eye.     The most common missed maculopathies that result in unhappy cataract patients are vitreoretinal     interface abnormalities, such as epiretinal membranes and vitreoretinal traction, according to Michael D. Ober, M.D., Retina Consultants of Michigan, Southfield.     "...",
        id: "6175",
        image: "images/New_Articles/2012/01/37.jpg",
        width: "202",
        height: "137"
    },
    {
        title: "Retinal ramifications on the phaco edge",
        author: "Maxine Lipner Senior EyeWorld Contributing Editor",
        content: "It is one of those things that can come as a double whammy—an older patient is diagnosed with age-related macular degeneration (ARMD) and also with a cataract. Prithvi Mruthyunjaya, M.D., assistant professor of ophthalmology, Duke Eye Center, Durham, N.C., finds that it is nearly ubiquitous at the time of ARMD diagnosis to also face a cataract. These patients present a unique set of challenges. What is a practitioner with such patients to do?      Dr. Mruthyunjaya usually begins by bringing to light for patients with dry ARMD the differing data that is available on the subject. The older literature, he explained, is in some conflict...",
        id: "6176",
        image: "images/New_Articles/2012/01/41.jpg",
        width: "171",
        height: "150"
    },
    {
        title: "Cataract surgery and diabetic retinopathy",
        author: "Faith A. Hayden EyeWorld Staff Writer",
        content: "Diabetic patients can be tough cases for cataract surgeons to work with, and managing diabetic retinopathy in prospective and current cataract patients is just one challenge in an already long line. As new data shows, the problem won't be going away anytime soon.     According to the 2011 National Diabetes Fact Sheet, which was released January 2011, 25.8 million children and adults in the U.S.—8.3% of the population—have diabetes. In adults 65 and order, 10.9 million, or 26.9% of all people in this age group, have diabetes. Furthermore, in 2010 alone, 1.9 million new cases of diabetes were diagnosed in people aged 20 years and older...",
        id: "6177",
        image: "images/New_Articles/2012/01/47.jpg",
        width: "173",
        height: "150"
    },
    {
        title: "Evaluating the risks of retinal detachment in cataract patients",
        author: "Michelle Dalton EyeWorld Contributing Editor",
        content: "Retinal detachments (RD) are more likely to occur in patients with higher myopia, and the risk increases if there's a family history of RD or if a patient's fellow eye has had one. In these patients, retinal specialists recommend extra vigilance when looking at the peripheral retina during normal pre-op exams before cataract surgery. Refractive lens exchange patients undergoing an IOL exchange are also at a higher risk. Complicated cataract surgery—cases involving vitreous loss or capsular rupture—also puts the patient at an increased risk of developing an RD. Another patient group at risk is people who have undergone refractive surgery and...",
        id: "6178",
        image: "images/New_Articles/2012/01/50.jpg",
        width: "191",
        height: "150"
    },
    {
        title: "Preventing and treating CME",
        author: "Vanessa Caceres EyeWorld Contributing Editor",
        content: "Think of prophylaxis for cystoid macular edema (CME) like life insurance, said Keith A. Warren, M.D., chair, ophthalmology department, School of Medicine,      University of Kansas, Kansas City.      Hopefully you won't need it, but it can give you some clinical peace of mind.      Uday Devgan M.D., chief of ophthalmology, Olive View–University of California, Los Angeles Medical Center, approaches CME with another analogy: "When CME occurs, it's like a carpet that's flooded. You can repair the carpet, but it's never quite the same," he said. That's why it's better to prevent CME after cataract surgery from occurring in the first place, Dr. Devgan said...",
        id: "6179",
        image: "images/New_Articles/2012/01/52.jpg",
        width: "137",
        height: "150"
    },
    {
        title: "Therapy on the anti-VEGF frontier",
        author: "Maxine Lipner Senior EyeWorld Contributing Editor",
        content: "Anti-VEGF therapy to fight neovascular eye disease recently got a boost when on November 18, 2011, EYLEA (Regeneron      Pharmaceuticals, Tarrytown, N.Y.), also known as VEGF Trap-Eye,      received FDA approval for wet AMD cases. This is one new anti-VEGF gaining ground in an area that has been dominated by Avastin      (bevacizumab, Genentech, South San Francisco) and Lucentis (ranibizumab, Genentech), considered breakthrough drugs in their own right for AMD patients. Investigators are also honing in on other drugs such as integrin peptide therapy. EyeWorld asked practitioners to offer their insights on these valuable drugs...",
        id: "6181",
        image: "images/New_Articles/2012/01/58.jpg",
        width: "183",
        height: "150"
    }];